Skip to content

Clinical trials

Phase 2 Uterine Cervical Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 2 Country / region: Taiwan Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20152
20181
20191
20201
20213
20231
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital4
Hoffmann-La Roche2
Agenus Inc.1
AstraZeneca1
BeiGene1
Buddhist Tzu Chi General Hospital1
Daiichi Sankyo1
Merck Sharp & Dohme LLC1
Pfizer1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms14
Endometrial Neoplasms4
Ovarian Neoplasms4
Esophageal Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Stomach Neoplasms2
Urinary Bladder Neoplasms2
Adenocarcinoma, Clear Cell1
Breast Neoplasms1
Carcinoma, Hepatocellular1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.